Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Apotea AB (publ)CHIX:APOTES 18 Earnings Yield (Joel Greenblatt) % is 4.07% as of Jun. 2026, which is 18% above its 10-year median of 3.46. GuruFocus rates CHIX:APOTES with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 681 Healthcare Providers & Services companies, Apotea AB (publ) ranks better than 53.74% on this metric.
Apotea AB (publ)'s Enterprise Value for the quarter that ended in Jun. 2026 was kr6,977 Mil.
Apotea AB (publ)'s EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was kr322 Mil. Apotea AB (publ)'s Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was 4.07%.
The historical rank and industry rank for Apotea AB (publ)'s Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
CHIX:APOTEs'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 2.48 Med: 3.46 Max: 4.84
Current: 4.13
During the past 5 years, the highest Earnings Yield (Joel Greenblatt) of Apotea AB (publ) was 4.84%. The lowest was 2.48%. And the median was 3.46%.
CHIX:APOTEs's Earnings Yield (Joel Greenblatt) % is ranked better than 53.74% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 3.52
vs CHIX:APOTEs: 4.13
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Apotea AB (publ)'s Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Apotea AB (publ) (CHIX:APOTEs) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Apotea AB (publ) Earnings Yield (Joel Greenblatt) % Related Terms
Apotea AB (publ) Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Apotea AB (publ)'s Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apotea AB (publ) Earnings Yield (Joel Greenblatt) % Chart
Apotea AB (publ) Earnings Yield (Joel Greenblatt) % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Apotea AB (publ)'s Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apotea AB (publ) Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apotea AB (publ)'s Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Apotea AB (publ)'s Earnings Yield (Joel Greenblatt) % falls into.
Apotea AB (publ) Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Apotea AB (publ)s Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
Apotea AB (publ)'s EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr322 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 4.07% mean?
Apotea AB (publ) (CHIX:APOTES) has a Earnings Yield (Joel Greenblatt) % of 4.07% as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Apotea AB (publ) and its competitors. This is 18% above median its historical median of 3.46. Over the past decade, Apotea AB (publ)'s Earnings Yield (Joel Greenblatt) % has ranged from 2.48 to 4.84. According to the industry distribution chart, Apotea AB (publ) ranks #315 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 46.3%.
Is Apotea AB (publ)'s Earnings Yield (Joel Greenblatt) % too high?
Apotea AB (publ)'s current Earnings Yield (Joel Greenblatt) % of 4.07% is 18% above median its 10-year median of 3.46. Over the past 10 years, this metric has ranged from a low of 2.48 to a high of 4.84. The Healthcare Providers & Services industry median Earnings Yield (Joel Greenblatt) % is 3.52. Apotea AB (publ)'s value of 4.07% is 15.6% above this industry median. Based on the distribution chart, Apotea AB (publ) ranks #315 out of 681 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Earnings Yield (Joel Greenblatt) % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Apotea AB (publ) ranks #315 out of 681 companies for Earnings Yield (Joel Greenblatt) %. This puts Apotea AB (publ) in the upper half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.52. Apotea AB (publ)'s value of 4.07% is 15.6% above this benchmark. Historically, Apotea AB (publ)'s own Earnings Yield (Joel Greenblatt) % has ranged from 2.48 to 4.84 over the past decade. While the company's 10-year median is 3.46 vs. the industry median of 3.52, Apotea AB (publ) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.52, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apotea AB (publ)'s current Earnings Yield (Joel Greenblatt) % of 4.07% is 15.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Apotea AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apotea AB (publ)'s current Earnings Yield (Joel Greenblatt) % is 4.07%, which is 18% above median its own 10-year median of 3.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (CHIX:APOTES) has a current Earnings Yield (Joel Greenblatt) % of 4.07%. The current Earnings Yield (Joel Greenblatt) % is 4.07%, which is 18% above median its 10-year median of 3.46 and 15.6% above the Healthcare Providers & Services industry median of 3.52. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Apotea AB (publ) (CHIX:APOTES), the current Earnings Yield (Joel Greenblatt) % is 4.07% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score
Get the complete analysis for CHIX:APOTES
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:APOTES has been successfully added to your 
